MFDS — authorised 22 February 2019
- Marketing authorisation holder: ACCORD HLTHCARE INC
- Status: likely_approved
🇰🇷 Busulfex in South Korea
MFDS authorised Busulfex on 22 February 2019
Marketing authorisation
Busulfex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Busulfex approved in South Korea?
Yes. MFDS authorised it on 22 February 2019.
Who is the marketing authorisation holder for Busulfex in South Korea?
ACCORD HLTHCARE INC holds the South Korean marketing authorisation.